Literature DB >> 8675931

The effects of hormone replacement therapy, lipoprotein cholesterol levels, and other factors on a clock drawing task in older women.

A Paganini-Hill1, V W Henderson.   

Abstract

OBJECTIVES: To assess the associations of a clock drawing task with hormone replacement therapy and other factors in older women.
DESIGN: Group comparisons.
SETTING: Leisure World Laguna Hills, retirement community in southern California. PARTICIPANTS: Two hundred ninety-two postmenopausal women who were analyzed for lipoprotein levels in 1987-88 were contacted by postal survey, which included a clock drawing task, in 1992; 168 women who drew normal clocks were compared with 46 who drew abnormal or blank clocks. MEASUREMENTS: Clock drawings; lipoprotein cholesterol levels; serum progesterone, estrone, estradiol, and steroid hormone binding globin levels; self-reported data on smoking, alcohol intake, prior medical diagnoses, and use of certain medications including hormone replacement therapy and analgesics.
RESULTS: Women with normal clocks had significantly lower total cholesterol (P = .01), LDL cholesterol (P = .03), and serum progesterone levels (P = .03). They weighed, on average, 5 more pounds at the time of last menstrual period (P = .05), were more likely to use combined hormonal replacement therapy (P = .06), and were less likely to use acetaminophen daily (P = .02) than women with abnormal clocks. Serum estrone and estradiol levels did not differ significantly between women with normal and abnormal clocks.
CONCLUSION: The associations found here suggest that high serum cholesterol and progesterone levels might have a negative effect on clock drawing performance. Acetaminophen may also be related to worse performance on this task.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675931     DOI: 10.1111/j.1532-5415.1996.tb03740.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  8 in total

Review 1.  Gonadal hormones and cognitive aging: a midlife perspective.

Authors:  Victor W Henderson
Journal:  Womens Health (Lond)       Date:  2011-01

Review 2.  The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: a critical and theoretical review.

Authors:  Ronald F Zec; Mehul A Trivedi
Journal:  Neuropsychol Rev       Date:  2002-06       Impact factor: 7.444

3.  Impact of plasma lipids and time on memory performance in healthy elderly without dementia.

Authors:  C Reitz; J Luchsinger; M-X Tang; J Manly; R Mayeux
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

4.  Progesterone to ovariectomized mice enhances cognitive performance in the spontaneous alternation, object recognition, but not placement, water maze, and contextual and cued conditioned fear tasks.

Authors:  Cheryl A Frye; Alicia A Walf
Journal:  Neurobiol Learn Mem       Date:  2008-05-01       Impact factor: 2.877

Review 5.  Estrogen and Alzheimer's disease: the story so far.

Authors:  Brenna Cholerton; Carey E Gleason; Laura D Baker; Sanjay Asthana
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Serum lipids and memory in a population based cohort of middle age women.

Authors:  V W Henderson; J R Guthrie; L Dennerstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

7.  Cognition, mood, and physiological concentrations of sex hormones in the early and late postmenopause.

Authors:  Victor W Henderson; Jan A St John; Howard N Hodis; Carol A McCleary; Frank Z Stanczyk; Roksana Karim; Donna Shoupe; Naoko Kono; Laurie Dustin; Hooman Allayee; Wendy J Mack
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

8.  Therapeutic approaches to age-associated neurocognitive disorders.

Authors:  R O'Hara; C Derouesné; K N Fountoulakis; J A Yesavage
Journal:  Dialogues Clin Neurosci       Date:  2001-09       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.